“…The literature describes a female predominance in the patient population, implying that some underlying comorbidities are gender-specific [ 4 , 5 ]. PRES can occur secondary to different conditions, including hypertension, systemic infections, COVID-19 [ 6 , 7 ], autoimmune diseases (systemic lupus erythematosus or Wegener’s granulomatosis), hemolytic uremic syndrome, thrombocytopenic thrombotic purpura, sickle cell disease [ 8 ], ventriculoperitoneal shunt insertion/overshunting [ 9 ], malignant tumors, chemotherapy or immunosuppression and drug toxicity (calcineurin inhibitors, cyclophosphamide, tacrolimus, azathioprine, erythropoietin, L-asparaginase and filgrastim) [ 10 , 11 , 12 ]. The most common clinical signs are headaches, seizures, acute confusion or an altered mental state and visual disturbances such as reversible cortical blindness [ 3 , 13 ].…”